Opposition within: Ajit Pawar-shaped hole in Maharashtra politics

Ajit Pawar's followers will now have to choose from three options: Run the party independently and evolve a space for it; go back to Sharad Pawar as their leader, or take shelter under the BJP's umbrella.

Urban is the new political, better cities need good politics

It is not only its size substantial that gives the urban population an increasing influence in the national scenario. It is the adoption of the urban as an ideal that gives the city its surging power.

Birds, ants, trees are nature's workers, let's listen to them

The Aravallis are old. Old enough to know better than to expect gratitude. Older than the Himalayas, older than our arguments. The low hills with no interest in grandeur. That, perhaps, is their biggest mistake.

Ruling party's historic opportunity: Frame future without grievance, with pride

India's civilisation has never been monolithic. To reduce this vast mosaic to a binary struggle between Hindus and Muslims is to betray the very essence of our civilisation.

Last decade was about the plumbing. Now it's pipeline

Welfare systems should increasingly act as launchpads, linking beneficiaries to skilling, micro-credit, local manufacturing clusters, and urban employment corridors.

India's consumption story and the underlying wage growth problem

The Year 2025-26 has been about supporting household consumption. First, the Union Budget presented last year lowered income tax rates under the new regime. Then, in September, the long-awaited rationalisation of the Goods and Services Tax (GST) was finally announced. Now, with the Union Budget for 2026-27 around the corner, it is expected that other segments will be in focus.

But it is worth examining if consumption -even after the supportive measures - is indeed doing well. The problem is that there is no clear answer.

India-EU trade deal: What it means for pharma sector

The India-Eu Free Trade Agreement (FTA) aims to significantly boost trade by reducing tariffs on pharmaceuticals while increasing EU access to India's medical devices and technology market. It seeks to restore export competitiveness for Indian generics and med-tech, though with pressure from the EU regarding intellectual property (IP) rules.